India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
At the 2025 Florida Chamber Insurance Summit, Insurance Commissioner Mike Yaworsky announced that Florida’s long‑volatile insurance market has at last regained stability. After a decade marked by runaway litigation, inflated claims, and insurer exits, the sweeping tort and insurance reforms passed in 2022 and 2023 have reversed the decline. Litigation has fallen to pre‑2019 levels, new carriers and reinsurers are entering the state, and consumers now have more options than they’ve seen in years. Yaworsky cautioned, however, that rolling back these reforms would undo the progress and impose massive costs on Floridians.
Driving with an expired license is illegal in nearly every state, and in 2025 the consequences are more serious than most people realize. From fines and potential jail time to denied insurance claims and professional repercussions, even a simple lapse can create a ripple effect—especially for licensed professionals in real estate, insurance, mortgage, and finance. This quick morning read breaks down the real penalties, why professionals should pay attention, and how to renew your license before it becomes a costly mistake.
A new wave of chat‑based AI tools is reshaping how quickly real estate professionals can prepare and enhance listing photos. By simply describing changes—like brightening a kitchen, removing clutter, or fully staging a room—agents and property managers can produce high‑impact images in minutes. This technology not only speeds up market readiness but also boosts renter and buyer engagement by presenting spaces at their full potential from the very first glance.
The rental market is gearing up for major shifts in 2026, from rising compliance demands and surging insurance costs to the rapid adoption of AI‑powered property management tools. Tenants’ expectations are evolving just as quickly, pushing owners to deliver lifestyle‑driven communities rather than simple lease agreements. Investors and operators who embrace technology, stay ahead of regulatory changes and prioritize renter experience will be best positioned to thrive in the coming year.
Artificial intelligence is transforming real estate at lightning speed, turning days of manual work into minutes of automated insight. With the AI real estate market projected to soar from $222.65B in 2024 to over $975B by 2029, professionals who understand this technology now will lead the industry tomorrow. From smarter valuations to automated workflows and predictive analytics, AI is redefining how agents, investors, and property managers operate—making today the perfect time to embrace the tools shaping the future of real estate.
As AI takes over the repetitive tasks that slow agents down, industry expert Matt Britton says the future of real estate belongs to professionals who combine intelligent automation with irreplaceable human trust. Speaking to thousands at NAR NXT 2025, Britton emphasized that the next wave of success will come from agents who embrace AI workflows while doubling down on what technology can’t replicate: empathy, creativity, and meaningful client relationships.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
